These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35239736)

  • 1. Evaluation of pharmacovigilance systems for reporting medication errors in Africa and the role of patients using a mixed-methods approach.
    Sabblah GT; Seaneke SK; Kushitor M; van Hunsel F; Taxis K; Duwiejua M; van Puijenbroek E
    PLoS One; 2022; 17(3):e0264699. PubMed ID: 35239736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.
    Ampadu HH; Hoekman J; de Bruin ML; Pal SN; Olsson S; Sartori D; Leufkens HG; Dodoo AN
    Drug Saf; 2016 Apr; 39(4):335-45. PubMed ID: 26754924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of adverse drug reaction reports in South Africa: An analysis of VigiBase® for the year 2017.
    Steyn H
    S Afr Med J; 2023 Jun; 113(6):26-33. PubMed ID: 37278262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and analysis of a database for medication errors in a pharmacovigilance centre-the Moroccan experience.
    Alj L; Benkirane R; Tebaa A; Benabdallah G; Zekaria A; Khattabi A; Soulaymani Bencheikh R
    Eur J Clin Pharmacol; 2021 Aug; 77(8):1235-1246. PubMed ID: 33598764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific features of medicines safety and pharmacovigilance in Africa.
    Isah AO; Pal SN; Olsson S; Dodoo A; Bencheikh RS
    Ther Adv Drug Saf; 2012 Feb; 3(1):25-34. PubMed ID: 25083223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.
    Jusot V; Chimimba F; Dzabala N; Menang O; Cole J; Gardiner G; Ofori-Anyinam O; Oladehin O; Sambakunsi C; Kawaye M; Stegmann JU; Guerra Mendoza Y
    Drug Saf; 2020 Jun; 43(6):583-593. PubMed ID: 32239447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase.
    Kröger E; Mouls M; Wilchesky M; Berkers M; Carmichael PH; van Marum R; Souverein P; Egberts T; Laroche ML
    Ann Pharmacother; 2015 Nov; 49(11):1197-206. PubMed ID: 26324356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct reporting of adverse drug reactions by healthcare consumers in Africa: a narrative review.
    Adedeji-Adenola H; Nlooto M
    Int J Clin Pharm; 2021 Feb; 43(1):11-24. PubMed ID: 32902780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting System.
    Pera V; van Vaerenbergh F; Kors JA; van Mulligen EM; Parry R; de Wilde M; Lahousse L; van der Lei J; Rijnbeek PR; Verhamme KMC
    Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5743. PubMed ID: 38158381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports.
    Wakao R; Taavola H; Sandberg L; Iwasa E; Soejima S; Chandler R; Norén GN
    Drug Saf; 2019 Dec; 42(12):1487-1498. PubMed ID: 31559542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania.
    Barry A; Olsson S; Minzi O; Bienvenu E; Makonnen E; Kamuhabwa A; Oluka M; Guantai A; Bergman U; van Puijenbroek E; Gurumurthy P; Aklillu E
    Drug Saf; 2020 Apr; 43(4):339-350. PubMed ID: 31919794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying high-risk medications and error types in Danish patient safety database using disproportionality analysis.
    Tchijevitch O; Birkeland SF; Bogh SB; Hallas J
    Pharmacoepidemiol Drug Saf; 2024 Feb; 33(2):e5735. PubMed ID: 38357842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting medication errors associated with the use of beta-lactams in the Russian Pharmacovigilance database.
    Kuzmina AV; Asetskaya IL; Zyryanov SK; Polivanov VA
    BMC Pharmacol Toxicol; 2021 Jan; 22(1):5. PubMed ID: 33419474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase.
    Star K; Norén GN; Nordin K; Edwards IR
    Drug Saf; 2011 May; 34(5):415-28. PubMed ID: 21513364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacovigilance network as an additional tool for the surveillance of antimicrobial resistance.
    Habarugira JMV; Figueras A
    Pharmacoepidemiol Drug Saf; 2021 Aug; 30(8):1123-1131. PubMed ID: 33864401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
    Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F
    Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.
    Kunac DL; Tatley MV
    Drug Saf; 2011 Jan; 34(1):59-71. PubMed ID: 21142271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication Errors Associated With Adverse Drug Reactions in Iran (2015-2017): A P-Method Approach.
    Karimian Z; Kheirandish M; Javidnikou N; Asghari G; Ahmadizar F; Dinarvand R
    Int J Health Policy Manag; 2018 Dec; 7(12):1090-1096. PubMed ID: 30709084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Descriptive analysis of medication errors reported to the Egyptian national online reporting system during six months.
    Shehata ZH; Sabri NA; Elmelegy AA
    J Am Med Inform Assoc; 2016 Mar; 23(2):366-74. PubMed ID: 26254479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.